Showing 168 results
-
Featured News /
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
-
Featured News /
-
Featured News /
-
Featured News /Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.
-
Featured News /September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.
-
Featured News /
-
Featured News /
-
Featured News /On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
-
Featured News /Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.
-
Featured News /This year, World Malaria Day is happening as countries around the world are fighting the COVID-19 pandemic.